US FDA warns of stroke risk with multiple sclerosis drug: industry news round-up

Written by Sharon Salt, Editor

In this week’s industry news round-up we cover the latest headlines on the clearance of gammaCore™ for cluster headache, warnings of stroke risk with a multiple sclerosis drug and an investigational gene therapy for spinal muscular atrophy. Find out more about our selection of the highlights below. Our selection of the highlights includes: gammaCore™ receives clearance for the preventive treatment of cluster headache US FDA warns of stroke risk with multiple sclerosis drug Investigational gene therapy (Zolgensma®) gains BLA acceptance for spinal muscular atrophy gammaCore™ receives clearance for the preventive treatment of cluster headache electroCore (NJ, USA) has announced that...

To view the full article, please register now for access

It's completely free